Albany Molecular Research (AMRI) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts AMRI Hot Sheet
Price: $21.74 --0%
Financial Fact:
Cost of contract revenue: 123.49M
Today's EPS Names:
KG, NHC, NATH, More
Financial Fact:
Cost of contract revenue: 123.49M
Today's EPS Names:
KG, NHC, NATH, More
Join SI Premium – FREE
Albany Molecular Research (NASDAQ: AMRI) reported Q3 EPS of $0.14, $0.01 better than the analyst estimate of $0.13. Revenue for the quarter came in at $101.4 million versus the consensus estimate of $95.15 million.
Albany Molecular Research reaffirmed FY2015 guidance.
For earnings history and earnings-related data on Albany Molecular Research (AMRI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
- Atlassian results seen as 'game changer' for AI kills software worries
- Alta Mesa Resources (AMR) Misses Q2 EPS by 128c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
